Scholar Rock Holding Corp (2QK)

Currency in EUR
32.20
+0.20(+0.63%)
Closed·
2QK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
32.2032.20
52 wk Range
6.3547.00
Key Statistics
Bid/Ask
32.00 / 32.40
Prev. Close
32
Open
32.2
Day's Range
32.2-32.2
52 wk Range
6.35-47
Volume
50
Average Volume (3m)
166
1-Year Change
274.86%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2QK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Scholar Rock Holding Corp Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Compare 2QK to Peers and Sector

Metrics to compare
2QK
Peers
Sector
Relationship
P/E Ratio
0.0x−1.7x−0.5x
PEG Ratio
0.00−0.030.00
Price/Book
0.0x0.9x2.6x
Price / LTM Sales
0.0x75.6x3.2x
Upside (Analyst Target)
0.0%311.1%41.2%
Fair Value Upside
Unlock14.5%6.2%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

2QK Income Statement

People Also Watch

268.39
AVAV
-0.83%
109.38
CRDO
+1.32%
43.790
RKLB
-2.93%
17.670
QBTS
-3.71%
85.63
RYTM
-0.06%

FAQ

What Stock Exchange Does Scholar Rock Holding Corp Trade On?

Scholar Rock Holding Corp is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Scholar Rock Holding Corp?

The stock symbol for Scholar Rock Holding Corp is "2QK."

What Is the Scholar Rock Holding Corp Market Cap?

As of today, Scholar Rock Holding Corp market cap is 3.06B.

What Is Scholar Rock Holding Corp's Earnings Per Share (TTM)?

The Scholar Rock Holding Corp EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 2QK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Scholar Rock Holding Corp Stock Split?

Scholar Rock Holding Corp has split 0 times.

What is the current trading status of Scholar Rock Holding Corp (2QK)?

As of 29 Jul 2025, Scholar Rock Holding Corp (2QK) is trading at a price of 32.20, with a previous close of 32.00. The stock has fluctuated within a day range of 32.20 to 32.20, while its 52-week range spans from 6.35 to 47.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.